Patient‐reported outcomes, postoperative pain and pain relief after day‐case surgery ( POPPY ): persistent postoperative opioid use prevalence and associations
Summary Introduction An increasing proportion of complex surgical procedures are being performed in the UK as day‐cases, and NHS targets aim for these to encompass ≥ 75% of all surgeries. There has been limited outcome follow‐up for this group of patients, particularly considering the prevalence of persistent postoperative opioid use and factors associated with its occurrence. Methods Data from POPPY, a national, prospective, observational study exploring outcomes following day‐case surgery in the UK, were used to estimate the prevalence of persistent postoperative opioid use at day 97 following surgery. Patient, anaesthetic and surgical factors associated with increased persistent postoperative opioid use were explored using multivariable analysis. Results Of the 7839 initially recruited patients, 3488 (44.5%) provided details of their analgesic medication at day 97 following surgery. The prevalence of daily persistent postoperative opioid use was estimated to be 11.8% (95%CI 11.1–13.2%). Patient factors associated with daily persistent postoperative opioid use were pre‐operative opioid use; opioid use at day 7; and composite pain scores (day 1, day 3 and day 7). Compared with general surgery, ENT, breast and orthopaedic surgery carried a higher risk of persistent postoperative opioid use. Patient factors associated with a reduced odds ratio of persistent postoperative opioid use were: female sex; higher composite pain score at baseline; and Index of Multiple Deprivation quintile 4. Daily persistent postoperative opioid use at day 97 following surgery was associated with reduced quality of life scores. Discussion Daily persistent postoperative opioid use is common in the UK following day‐case surgery. Patient and surgical factors that are associated with an increased risk of this outcome could be used to drive improvement in identification of at‐risk patients pre‐operatively and optimise postoperative prescribing pathways.
Authors
- Matthew Everson
- Adam B. Brayne (ORCID: https://orcid.org/0000-0002-2000-9251)
- Lexy Sorrell (ORCID: https://orcid.org/0000-0001-8044-3706)
- Harriet Daykin
- Anna Ratcliffe
- Martha Belete (ORCID: https://orcid.org/0009-0008-9791-084X)
- Mark Rockett (ORCID: https://orcid.org/0000-0001-8907-4396)
- the POPPY study delivery group
- William Hare
Institutions
- Torbay Hospital (GB)
- Torbay and South Devon NHS Foundation Trust (GB)
- University Hospitals Plymouth NHS Trust (GB)
- Royal Devon University Healthcare NHS Foundation Trust (GB)
- University of Plymouth (GB)
Publication Details
- Journal
- Anaesthesia
- Published
- 2026-11-21
- DOI
- https://doi.org/10.1111/anae.70447
- Primary Topic
- Opioid Use Disorder Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00